Ageing and remyelination failure in people with multiple sclerosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Advancing age may reduce the capacity for remyelination in multiple sclerosis (MS). However, age is not a barrier to remyelination, and targeting aging processes could enhance therapies.
Area Of Science
- Neuroscience and Neurology
- Regenerative Medicine
Background
- Enhancing endogenous remyelination is a key strategy for managing multiple sclerosis (MS) disability progression.
- Preclinical studies link aging to remyelination failure, but human evidence in MS is less conclusive.
- Clarifying the impact of age on remyelination is crucial for developing effective MS therapies.
Purpose Of The Study
- To review and synthesize existing evidence on the impact of age on remyelination in multiple sclerosis.
- To explore challenges in measuring human remyelination and its relationship with aging.
Main Methods
- Review of pathological, imaging, and clinical studies investigating age-related remyelination in multiple sclerosis.
- Analysis of challenges in human remyelination assessment.
Main Results
- Current evidence suggests a reduced capacity for remyelination with increasing age in multiple sclerosis patients.
- Findings are sometimes inconsistent, and the exact contribution of aging to remyelination failure remains unclear.
- Pathological data indicate remyelination can occur across all ages, with no strict age cut-off.
Conclusions
- Ageing appears to impair remyelination in multiple sclerosis, though not completely.
- The effect of age may differ based on lesion location.
- Targeting the biology of aging presents a potential therapeutic strategy to enhance remyelination in MS.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...